2. Classification of Life Sciences Industry
Life Sciences
Industry
Biotechnology Pharmaceuticals Medical Devices Healthcare
Source: MarketResearch.com; Feb 2013
3. Pharmaceutical Market Outlook: Global vs.
Indian
Global Pharmaceutical Market Indian Pharmaceutical
900 880 Market
Market Size in US$ Billion
850
Market Size in US$ Billion
20 18
800 18
16
750 14
12 11
750
10
8
700 6
4
2
650 0
2011 2012 2011 Year 2012
Year
Source
1.Economic Times; Dec 2012
2. Financial Express ; Jan 2012
3. Euler Hermes; March 2012
4. International Federation of Pharmaceutical
Wholesalers; Jan 2012
4. Biotechnology Market Outlook: Global vs. Indian
283 Global Biotechnology Market
281.7
Indian Biotechnology Market
282
4.35
281 4.3
Market Size in US$ Billion
4.3
Market Size in US$ Billion
280
4.25
279 4.2
278 4.15
277 4.1
275.757 4.05
276 4
275 4
3.95
274
3.9
273
3.85
272 2011 2012
2011 2012
Year
Year
Source:
1. Association for Biotechnology Led Enterprises;
Sep 2012
2. India Brand Equity Forum; Feb 2013
3. PR Newswire; Sep 2012
4.Checkbiotech; May 2011
5. Medical Devices Market: Global vs. Indian
Global Medical Devices Market
Global Medical Devices Market Size in US$ Billion
320
Indian Medical Devices
310 307.7
Market
Indian Medical Devices Market Size in
4.05
300 4
4
290 3.95
US$ Billion
3.9
280
3.85
3.8
270 266
3.75
3.7
260 3.7
3.65
250
3.6
240 3.55
FY11 FY12 FY11 FY12
Year Year
Source:
1. PR Newswire; Nov 2011
2. MedicalDeviceSummit; Feb 2013
3. PR Newswire; Sep 2012
4. Espicom Business Intelligence; Aug 2012
6. Socio-Economic Growth Drivers for Indian
Pharma, Biotech & Medical Devices: I
Foreign Direct Investment
Indian Biotech Giant Biocon and US drugmaker Mylan signed a JV in 2009 to develop five
biosimilar products.
In November 2012, Biocon entered into partnership with US drugmaker Bristol-Myers Squibb
for its oral insulin pill IN-105.
In October 2012, Fidelity Growth Partners India invested Rs 400 crore in Trivitron, a Global
Medical Technology company of Indian Origin.
Exports
Value of Export of Indian Drugs, Pharmaceuticals and Fine chemicals has risen from Rs 12,826
crore in 2002 to Rs 47,551 crore in 2011.
Government Incentives
Government of India has dispensed Rs 205 crore as scholarships for women scientists. The
scholarships were given under the Women Scientists Scholarship Scheme (WSSS), Ministry of
Science and Technology, reportedly in December 2012.
Association for Biotechnology Led Enterprises (ABLE) and Washington Biotechnology &
Biomedical Association (WBBA) signed a MoU in October 2012 to support research in
healthcare.
Source:
1.Economic Times; Oct 2012
2. The Hindu Business Line; Dec 2012
3. Economic Times; Nov 2012
4. Annual Report 2011-12, Department of
Pharmaceuticals
7. Socio-Economic Growth Drivers for Indian
Pharma, Biotech & Medical Devices: II
Aging Population
Percentage of total Indian population greater than or equal to 65 years of age is expected
to rise to approximately 7% by 2016
Growth of Chronic Diseases
Percentage of total Indian population with at least one chronic disease is expected to rise
to approximately 13.5% by 2016
Rising Income Levels
Middle Class Consumption is expected to rise to 23% by 2030
Increased Medical Awareness
Due to path- breaking advancements in Information Technology over the past
decade, people have become better informed about health issues
Source: Frost & Sullivan; Oct 2012
8. Trends in Indian Life Sciences Industry
• Amount of FDI (in crores) increased
Investments from Rs 18486 crore (2000) to Rs
1233378 crore (2010)
CAGR over • Biotechnology (FY12)-19%
• Pharmaceuticals (FY12)-15%
last 5 years • Medical Devices (FY11)- 17%
Sources:
1. Research Journal of Management; Sep 2012 2. Indian Brand Equity Forum; Feb 2013 3. Deloitte Report; Dec 2011 4.
Economic Times; June 2012 5. Financial Express; Jan 2013
Abbreviations-CAGR: Compound Annual Growth Rate; FY-Fiscal Year
